Poster
4 |
Evaluation Of Antitrypanosomal Activity And Selectivity Of Natural And Semi-Synthetic Triterpenic Derivatives |
Human African trypanosomiasis, so called sleeping sickness, is a parasitic infection endemic in 36 African countries with about 3,000 new cases registered each year and 13 million people at risk of infection in 2015 [1]. This neglected disease, due to Trypanosoma brucei, may evolve into a neurological disease and be lethal if non treated. A promising source of new active compounds, as alternative to limited and toxic actual medications, could be natural compounds [2, 3] such as bioactive pentacyclic triterpenes [4] some of them being identified in a Beninese traditionally used plant, Keetia leucantha [5].
The purpose of this work was 1-to study structure-activity relationships with other triterpenic derivatives identified in the Keetia gender, semi-synthetized or commercialized to define structural key positions and improve selective activity and 2- to evaluate the in vivo activity of plant extract and the most promising compounds. Tests were performed on Trypanosoma brucei brucei (strain 427) and selectivity measured on the mammalian WI38 cells.